Chemists' body promises to help in the distribution of Covid-19 vaccine

Chemists have noted that vaccines may require a line of cold chains right from the point of production to the point of delivery to the administration of the dose to a person

Coronavirus, vaccine, covid
All kinds of vaccines have been successfully distributed by its members, says AIOCD President
BS Reporter New Delhi
1 min read Last Updated : Oct 21 2020 | 7:02 PM IST
The All India Organisation of Chemists and Druggists (AIOCD), the lobby group of 850,000 chemists across the country, has written to the Prime Minister's Office (PMO) assuring their assitance in the distribution of the Covid-19 vaccine across the country.

In their letter, the chemists have noted that vaccines may require a line of cold chains right from the point of production to the point of delivery to the administration of the dose to a person. All kinds of vaccines have been successfully distributed by its members, said AIOCD President Jagannath Shinde.  "All required infrastructure is available with our trade members to manage an intact cold chain with experience. We appeal therefore, to advise the concerned ministry and department to issue guidelines for the use of our channel members for the distribution of Covid-19 vaccines. We assure our best services to reach out to common citizens in the nooks and corners of our country," the letter to the PMO read.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus Vaccine

Next Story